Apheresis refers to the process of collecting specific blood components. These collected blood components, depending on the patient's condition, are replaced with similar blood components received from donors. It is a technique of separating the cellular and soluble components of blood using a cell separator, either by the centrifuge process or the filtration process. After the separation, the desired components of the blood are removed while the remaining blood components are reinfused back into the patient. The entire procedure is painless and takes typically two hours or slightly longer than blood donation.
The growth of the apheresis market can be attributed to factors, such as the increasing number of diseases, a rise in the demand for blood components & associated safety, technological advancement in the development of new apheresis techniques and reimbursement policies & funding for apheresis procedures. As per the U.S. Department of Health & Human Services, six in ten Americans live with at least one chronic disease - heart disease, cancer, or diabetes. This leads to an increased demand for apheresis. Additionally, with the growing number of surgeries and surgical techniques, advanced treatments have led to the global demand for blood & blood components. Additionally, the development and modernization of healthcare facilities are supporting market growth.
Major Key Players of the Apheresis Market are:TERUMO BCT, INC., Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation., KANEKA CORPORATION, KAWASUMI LABORATORIES. INC., Nikkiso Co., Ltd, and others.
Read More @ http://www.sbwire.com/press-releases/apheresis-market-to-witness-huge-growth-from-2020-2030-and-focusing-on-top-key-players-terumo-bct-fresenius-se-co-haemonetics-1289116.htm
The growth of the apheresis market can be attributed to factors, such as the increasing number of diseases, a rise in the demand for blood components & associated safety, technological advancement in the development of new apheresis techniques and reimbursement policies & funding for apheresis procedures. As per the U.S. Department of Health & Human Services, six in ten Americans live with at least one chronic disease - heart disease, cancer, or diabetes. This leads to an increased demand for apheresis. Additionally, with the growing number of surgeries and surgical techniques, advanced treatments have led to the global demand for blood & blood components. Additionally, the development and modernization of healthcare facilities are supporting market growth.
Major Key Players of the Apheresis Market are:TERUMO BCT, INC., Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation., KANEKA CORPORATION, KAWASUMI LABORATORIES. INC., Nikkiso Co., Ltd, and others.
Read More @ http://www.sbwire.com/press-releases/apheresis-market-to-witness-huge-growth-from-2020-2030-and-focusing-on-top-key-players-terumo-bct-fresenius-se-co-haemonetics-1289116.htm
No comments:
Post a Comment